Gsk PLC ORD 31 1/4P/ GB00BN7SWP63 /
3/24/2023 6:03:12 PM | Chg. -36.6 | Volume | Bid6:30:00 PM | Ask6:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,401.2GBX | -2.55% | 11.7 mill. Turnover(GBP): 97.4 mill. |
1,370.0Bid Size: 500 | 1,456.0Ask Size: 350 | 140.15 bill.GBP | - | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 0.88 GBP | -24.16% |
EPS Diluted: | 0.87 GBP | -24.10% |
Revenues per Share: | 3.41 GBP | -0.50% |
Book Value per Share: | 1.50 GBP | 2.65% |
Cash Flow per Share: | 0.79 GBP | -6.30% |
Dividend per Share: | 0.80 GBP | 0.00% |
Total | in mill. | |
Revenues: | 34,114.00 GBP | 0.04% |
Net Income: | 4,385.00 GBP | -23.73% |
Operating Cash Flow: | 7,952.00 GBP | - |
Cash and Cash Equivalents: | 4,274.00 GBP | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 15.99 | 18.33 |
P/S Ratio: | 4.11 | 4.71 |
P/BV ratio: | 9.31 | 10.67 |
P/CF Ratio: | 17.62 | 20.21 |
PEG: | -0.66 | -0.76 |
Earnings Yield: | 6.25% | 5.45% |
Dividend Yield: | 5.71% | 4.98% |
Market Capitalization | ||
Market Capitalization: | 140.15 bill. GBP | 160.7 bill. GBP |
Free Float Market Cap.: | - GBP | - GBP |
Market Cap. / Employee: | 777,790.7925 GBP | 891,806.2955 GBP |
Shares Outstanding: | 5.08 bill. |
Profitability
Gross Profit Margin: | 65.99% |
EBIT Margin: | 18.18% |
Net Profit Margin: | 12.85% |
Return on Equity: | 29.13% |
Return on Assets: | 5.54% |
Financial Strength
Liquidity I / Cash Ratio: | 18.06% |
Liquidity II / Quick Ratio: | 18.06% |
Liquidity III / Current Ratio: | 78.89% |
Debt / Equity Ratio: | 425.43% |
Dynam. Debt / Equity Ratio: | 805.43% |
Efficiency
Employees: | 90,096 |
Personal Expenses / Employee: | 99,926.74 GBP |
Revenues / Employee: | 378,640.56 GBP |
Net Income / Employee: | 48,670.31 GBP |
Total Assets / Employee: | 877,985.70 GBP |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | IFRS |
Currency: | GBP |